Celaid Therapeutics will participate in several speaking sessions at BioJapan 2026, to be held at PACIFICO Yokohama from Wednesday, October 7 to Friday, October 9, 2026.
Our CEO, Nobuyuki Arakawa, and Chief Development Officer, Asako Uchiyama, are scheduled to speak at the following sessions:
October 7, 11:15 AM–
JHVS (Japan Healthcare Venture Summit) SHOWCASE
Speaker: Nobuyuki Arakawa
October 8, 10:00–10:30 AM
Presentation at the University of Tokyo Booth
Speaker: Nobuyuki Arakawa
October 8, 11:30 AM–12:30 PM | Venue: F205
The University of Tokyo Edge Capital Partners (UTEC)
Investment Forum: “How Can Science from Japan Reach the Global?”
Speaker: Asako Uchiyama
BioJapan is one of Asia’s largest partnering events for the biotechnology industry, bringing together a wide range of participants from across the global bio-business community.
We look forward to welcoming you at BioJapan 2026.
